Diagnostic Value of C-reactive Protein for Detection of Postoperative Inflammatory Complications After Gastroesophageal Cancer Surgery

Given Indication for Gastroesophageal Cancer Surgery Clinical Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01249534
• Other study ID #: EKSG10/144
• Status: Completed
• Phase: N/A
• First received: November 29, 2010
• Last updated: December 9, 2010
• Start date: December 2010
• Est. completion date: December 2010

Study information

• Verified date: November 2010
• Source: Cantonal Hospital of St. Gallen
• Contact: n/a
• Is FDA regulated: No
• Health authority: Switzerland: Ethikkommission
• Study type: Observational

Clinical Trial Summary

Although widely used, there is a lack of evidence concerning diagnostic value of C-reactive protein (CRP) in the postoperative course. The aim of this study was to evaluate the diagnostic accuracy of CRP for postoperative inflammatory complications after gastroesophageal cancer.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 200
• Est. completion date: December 2010
• Est. primary completion date: December 2010
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• all patients with gastroesophageal cancer surgery

Exclusion Criteria:

• lack of measurement of C-reactive protein

Study Design

Observational Model: Cohort, Time Perspective: Retrospective

Related Conditions & MeSH terms

• Given Indication for Gastroesophageal Cancer Surgery

Intervention

Other:
• gastroesophageal cancer surgery
gastroesophageal cancer surgery

Locations

Country	Name	City	State
Switzerland	Department of surgery	St. Gallen

Sponsors (1)

Lead Sponsor	Collaborator
Cantonal Hospital of St. Gallen

Country where clinical trial is conducted

Switzerland, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	postoperative Inflammatory complications		30 days postoperatively	No